Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
39.21
-0.33 (-0.83%)
At close: Jun 5, 2025, 4:00 PM
39.10
-0.11 (-0.28%)
After-hours: Jun 5, 2025, 4:38 PM EDT

Sarepta Therapeutics Stock Forecast

Stock Price Forecast

According to 23 professional analysts, the 12-month price target for Sarepta Therapeutics stock ranges from a low of $40 to a high of $230. The average analyst price target of $125.43 forecasts a 219.89% increase in the stock price over the next year.

Price Target: $125.43 (+219.89%)
Analyst Consensus: Buy
Target Low Average Median High
Price $40 $125.43 $113 $230
Change +2.01% +219.89% +188.19% +486.59%

Analyst Ratings

The average analyst rating for Sarepta Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 665566
Buy 131211121212
Hold 113455
Sell 000000
Strong Sell 222100
Total 222121222323

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$40
Hold Reiterates $40 +2.01% May 22, 2025
JP Morgan
JP Morgan
Buy
Maintains
$169$84
Buy Maintains $169$84 +114.23% May 20, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$115$100
Buy Maintains $115$100 +155.04% May 8, 2025
RBC Capital
RBC Capital
Hold
Maintains
$87$58
Hold Maintains $87$58 +47.92% May 7, 2025
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$178$100
Strong Buy Maintains $178$100 +155.04% May 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
2.61B
from 1.90B
Increased by 37.38%
Revenue Next Year
2.95B
from 2.61B
Increased by 13.05%
EPS This Year
-1.94
from 2.34
EPS Next Year
6.59
from -1.94
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
540.10M701.89M933.01M1.24B1.90B2.61B2.95B3.17B
Revenue Growth
41.82%29.96%32.93%33.26%52.97%37.38%13.05%7.21%
EPS
-7.11-5.15-8.03-5.802.34-1.946.599.31
EPS Growth
-------41.39%
Forward PE
------5.954.21
No. Analysts
-----282716
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 3.0B 3.9B 4.0B
Avg 2.6B 3.0B 3.2B
Low 2.3B 2.3B 1.7B

Revenue Growth

Revenue Growth 20252026202720282029
High
55.8%
50.7%
35.3%
Avg
37.4%
13.1%
7.2%
Low
21.3%
-12.6%
-41.7%

EPS Forecast

EPS 20252026202720282029
High 4.01 14.18 15.27
Avg -1.94 6.59 9.31
Low -5.63 1.80 1.11

EPS Growth

EPS Growth 20252026202720282029
High
71.5%
-
131.8%
Avg - -
41.4%
Low - -
-83.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.